Potential Anticancer Mechanisms of a Novel EGFR/DNA-Targeting Combi-Molecule (JDF12) against DU145 Prostate Cancer Cells: An iTRAQ-Based Proteomic Analysis. [electronic resource]
- BioMed research international 2017
- 8050313 p. digital
Publication Type: Journal Article
2314-6141
10.1155/2017/8050313 doi
Antineoplastic Agents--pharmacology Cell Line, Tumor ErbB Receptors--antagonists & inhibitors Gene Expression Regulation, Neoplastic--genetics Humans Male Molecular Targeted Therapy Neoplasm Proteins--genetics Prostatic Neoplasms--drug therapy Protein Interaction Maps--genetics Signal Transduction--drug effects